BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 30, 2025
Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Jari, Genmab To Develop Antibodies For Inflammation

July 17, 2002
By Cormac Sheridan

Swiss Start-Up Addex Raises CHF15.75M To Treat Addiction

July 17, 2002
By Cormac Sheridan

Jari, Genmab To Develop Antibodies For Inflammation

July 17, 2002
By Cormac Sheridan

Elan Seeking US$1B In Asset Sale As Top Executive Departs

July 10, 2002
By Cormac Sheridan

Elan Seeking US$1B In Asset Sale As Top Executive Departs

July 10, 2002
By Cormac Sheridan
DUBLIN, Ireland - The top slot at ailing Irish biopharmaceutical firm Elan Corp. plc became available Tuesday as Chairman and CEO Donal Geaney vacated both roles, following a share price meltdown last Thursday, when Standard & Poor's reduced the company's debt rating to junk bond status. (BioWorld International)
Read More

Elan Seeking US$1B In Asset Sale As Top Executive Departs

July 10, 2002
By Cormac Sheridan

Elan Seeking US$1B In Asset Sale As Top Executive Departs

July 10, 2002
By Cormac Sheridan
DUBLIN, Ireland - The top slot at ailing Irish biopharmaceutical firm Elan Corp. plc became available Tuesday as Chairman and CEO Donal Geaney vacated both roles, following a share price meltdown last Thursday, when Standard & Poor's reduced the company's debt rating to junk bond status. (BioWorld International)
Read More

Inoxell, Rigel Settle Patent Dispute On Target Identification Technology

July 3, 2002
By Cormac Sheridan

Biovitrum Sells Off Plasma Business To Swiss Company

July 3, 2002
By Cormac Sheridan

Personal Chemistry Completes $31.6M Round Of Financing

July 3, 2002
By Cormac Sheridan
Previous 1 2 … 322 323 324 325 326 327 328 329 330 … 335 336 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 30, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 29, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing